Bio-Techne (TECH) Cash from Investing Activities Growth (1y) (2010 - 2026)
Bio-Techne (TECH) Cash from Investing Activities Growth (1y) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Bio-Techne |
9.04 Bn |
8.83 Bn |
208.29 Mn |
34.44% |
| Date | Value |
|---|
| Mar 31, 2026 |
34.44% |
| Dec 31, 2025 |
-17.67% |
| Sep 30, 2025 |
102.79% |
| Jun 30, 2025 |
104.61% |
| Mar 31, 2025 |
46.03% |
| Dec 31, 2024 |
78.74% |
| Sep 30, 2024 |
85.93% |
| Jun 30, 2024 |
-85.20% |
| Mar 31, 2024 |
93.18% |
| Dec 31, 2023 |
-21,616.51% |
| Sep 30, 2023 |
-682.76% |
| Jun 30, 2023 |
74.39% |
| Mar 31, 2023 |
-569.84% |
| Dec 31, 2022 |
99.69% |
| Sep 30, 2022 |
-176.52% |
| Jun 30, 2022 |
91.82% |
| Mar 31, 2022 |
-28,001.55% |
| Dec 31, 2021 |
-308.74% |
| Sep 30, 2021 |
12.51% |
| Jun 30, 2021 |
-2,066.55% |
